Filing Details
- Accession Number:
- 0001069530-19-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-19 18:06:00
- Reporting Period:
- 2019-12-19
- Accepted Time:
- 2019-12-19 18:06:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069530 | Cassava Sciences Inc | SAVA | Pharmaceutical Preparations (2834) | 911911336 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532303 | Eric Schoen | C/O Cassava Sciences, Inc. 7801 N. Capital Of Texas Hwy.; Suite 260 Austin TX 78731 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-19 | 5,300 | $1.88 | 15,300 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
